Johnson & Johnson
JNJ
#19
Rank
NZ$956.63 B
Marketcap
NZ$397.06
Share price
1.42%
Change (1 day)
49.55%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Market capitalization of Johnson & Johnson (JNJ)

Market cap: NZ$956.63 Billion

As of February 2026 Johnson & Johnson has a market cap of NZ$956.63 Billion. This makes Johnson & Johnson the world's 19th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Johnson & Johnson from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$956.63 B10.75%
2025NZ$863.75 B39.49%
2024NZ$619.22 B3.78%
2023NZ$596.64 B-17.98%
2022NZ$727.43 B10.33%
2021NZ$659.34 B14.83%
2020NZ$574.20 B0.71%
2019NZ$570.18 B11.32%
2018NZ$512.20 B-3.09%
2017NZ$528.52 B16.8%
2016NZ$452.48 B8.96%
2015NZ$415.27 B11.8%
2014NZ$371.45 B18.16%
2013NZ$314.37 B32.78%
2012NZ$236.76 B3.18%
2011NZ$229.46 B4.22%
2010NZ$220.16 B-10.02%
2009NZ$244.67 B-14.47%
2008NZ$286.05 B15.66%
2007NZ$247.31 B-8.78%
2006NZ$271.12 B3.66%
2005NZ$261.54 B-0.95%
2004NZ$264.06 B11.95%
2003NZ$235.86 B-22.57%
2002NZ$304.62 B-29.76%
2001NZ$433.69 B31.51%
2000NZ$329.76 B32.99%
1999NZ$247.96 B15.92%
1998NZ$213.91 B40.09%
1997NZ$152.70 B62.74%
1996NZ$93.83 B

End of Day market cap according to different sources

On Feb 5th, 2026 the market cap of Johnson & Johnson was reported to be:

NZ$956.43 Billion
by Nasdaq info icon info icon
NZ$956.63 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
NZ$496.92 B-48.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$251.49 B-73.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$317.01 B-66.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$220.48 B-76.95%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$1.528 T 59.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$192.60 B-79.87%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
NZ$309.47 B-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$231.43 B-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$499.45 B-47.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$198.26 B-79.28%๐Ÿ‡ฌ๐Ÿ‡ง UK